Selective enhancement of antagonist ligand binding at muscarinic M 2 receptors by heparin due to receptor uncoupling

By Shou Z.W.   Edmundson R.   Sheng Z.Z.   El-Fakahany E.E.  

European Journal of Pharmacology, Vol. 296, Iss. 1, 1996-01 ,pp. : 113-118

Elsevier

Access to resources Recommend Favorite

The (S)-(+)-enantiomer of dimethindene: a novel M 2 -selective muscarinic receptor antagonist

By Pfaff O.   Hildebrandt C.   Waelbroeck M.   Xue H.   Moser U.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 229-240

Elsevier

Access to resources Recommend Favorite

A novel muscarinic M 4 receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M 2 receptor sub-type

By Kitaichi K.   Day J.C.   Quirion R.  

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 53-56

Elsevier

Access to resources Recommend Favorite

Darifenacin: a novel M₃ muscarinic selective receptor antagonist for the treatment of overactive bladder

By Chapple Christopher R  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1493-1500

Informa Healthcare

Access to resources Recommend Favorite

SCH 57790, a selective muscarinic M 2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

By Carey G.J.   Billard W.   Binch H.   Cohen-Williams M.   Crosby G.   Grzelak M.   Guzik H.   Kozlowski J.A.   Lowe D.B.   Pond A.J.   Tedesco R.P.   Watkins R.W.   Coffin V.L.  

European Journal of Pharmacology, Vol. 431, Iss. 2, 2001-11 ,pp. : 189-200

Elsevier

Access to resources Recommend Favorite